CYAB · Cyabra, Inc.
$0.30
+0.01 (+4.66%)
At close · Aug 21
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the projected cash flows and cash balance as of June 30, 2026, management is of the opinion that without further fund raising it will not have sufficient resources to enable it to continue its operating activities, including the development and marketing of its products for a period of 12 months from the balance sheet date of these consolidated financial statements. As a result, there is a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$5.25M
Shares
17.60M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Yael Sandler | Chief Financial Officer | Appointed | 2026-03-31 |
| Emmanuel Heymann | Chief Revenue Officer | Appointed | 2026-03-31 |
| Dan Brahmy | Chief Executive Officer | Appointed | 2026-03-31 |
| Yossef Daar | Chief Product Officer | Appointed | 2026-03-31 |
| Ido Shraga | Chief Technology Officer | Appointed | 2026-03-31 |
| Yosef Eichorn | member of the Board | Resigned | 2026-03-31 |
| Dan Brahmy | Class III director | Appointed | 2026-03-31 |
| Josette Sheeran | Class III director | Appointed | 2026-03-31 |
| Sonny Vu | Class II director | Appointed | 2026-03-31 |
| Yossef Daar | Class III director | Appointed | 2026-03-31 |
| James Flanagan | Class I director | Appointed | 2026-03-31 |
| Michael Madon | Class II director | Appointed | 2026-03-31 |
| Michael Pompeo | Class I director | Appointed | 2026-03-31 |
| Yosef Eichorn | member of the Board | Resigned | 2026-03-31 |
Key facts
CIK
2032341
CUSIP
23249H105
13F (30d)
14 filings
14 filers
Visit website
Investor relations